In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exact Sciences Corp.

https://www.exactsciences.com/

Latest From Exact Sciences Corp.

PAVmed Plans Spin-Off And Marketing Push For Lucid Diagnostics

Lucid, which markets the EsoGuard test for Barrett’s esophagus, will become a separate public company, either through an IPO or a business combination with a health care SPAC.

M & A Cancer

Exact Sciences Acquires Ashion Analytics To Accelerate Sequencing Technology

The addition of the Arizona-based sequencing lab builds on Exact’s recent license of the TARDIS liquid biopsy technology from TGen.

M & A In Vitro Diagnostics

Guardant Health Launches Liquid Biopsy Test For Detecting Colorectal Cancer Recurrence

Guardant wants to become “one-stop-shop” in the cancer care continuum with the launch of an early-stage colorectal cancer test and planned launch of a tissue-based test.

Launches Research & Development

Pandemic Leaves Medtech With $500bn In M&A Firepower

EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Laboratory Testing Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Other Names / Subsidiaries
    • Base Genomics
    • Genomic Health, Inc.
    • Paradigm Diagnostics, Inc.
    • Thrive Earlier Detection Corp.
    • Viomics, Inc.
UsernamePublicRestriction

Register